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The TET enzymes convert methylcytosine to the newly discovered base hydroxymethylcytosine. 
While recent reports suggest that TETs may play a role in response to oxidative stress, this 
role remains uncertain, and results lack in vivo models. Here we show a global decrease of 
hydroxymethylcytosine in cells treated with buthionine sulfoximine, and in mice depleted for the 
major antioxidant enzymes GPx1 and 2. Furthermore, genome-wide profiling revealed differentially 
hydroxymethylated regions in coding genes, and intriguingly in microRNA genes, both involved in 
response to oxidative stress. These results thus suggest a profound effect of in vivo oxidative stress 
on the global hydroxymethylome.
In 2009, Anjana Rao’s laboratory showed that the ten eleven translocation (TET) enzymes (TET1, TET2, 
TET3) oxidize methylcytosine (mC) to hydroxymethylcytosine (hmC)1. In this reaction, the TET pro-
teins use Fe2+, O2 and α -ketoglutarate as co-substrates, the latter being converted into succinate during 
Krebs cycle1. The Krebs cycle determines the redox state of cells, and a defective Krebs cycle has been 
linked to elevated levels of cellular oxidative stress2. Oxidative stress is intimately involved in chronic 
inflammation, which in turn is a mediator in the pathology of diseases such as cancer or neurodegen-
erative disorders3,4.
Recently, two publications have described the effects of quinones on the TET proteins. The authors 
found a global increase in genomic hydroxymethylcytosine in response to quinone treatment5,6. Quinones 
are toxic, redox-active cyclic compounds that can induce oxidative stress; however, they are also able to 
be strong reducers as exemplified by the antioxidant effect of hydroquinone against superoxide radical7. 
Quinones also act as “Michael acceptors” and covalently bind to cellular nucleophiles to form DNA/
RNA and protein adducts8. This makes it hard to determine whether the hmC increase observed upon 
treatment with quinones is due to oxidative stress or has another explanation. Additionally, Scola et al. 
have observed a small increase in genomic hmC in rotenone-treated cortical neurons, yet the doses used 
in this study were not tested to produce oxidative stress9. Importantly, none of the above studies exploited 
in vivo models of oxidative stress, such as GPx or Sod knockout mice10.
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Despite the above-mentioned advances, the impact of oxidative stress on TET-mediated hydroxyme-
thylation is therefore unclear. We have addressed this issue using two experimental models, namely SY5Y 
neuroblastoma cells treated with buthionine sulfoximine (BSO), one of the most commonly used drug to 
induce oxidative stress, and Glutathione peroxidase 1 and 2 (GPx1/2) double-knockout mice. Our results 
show, for the first time, that both exogenous and in vivo oxidative assaults deeply modify the hydrox-
ymethylome. Of particular interest, we unveiled an unexpected link between oxidative-stress-induced 
hydroxymethylation pattern changes, a set of microRNAs, and oxidative-stress-related genes.
Results
BSO-treated SY5Y cells and GPx1/2 double-knockout mice have a decreased level of hydrox-
ymethylcytosine. To see whether hmC levels are affected in cells exposed to exogenous oxidative 
stress, we treated SY5Y cells with BSO and quantified hmC by dot-blot experiments and mass spectrom-
etry (LC/MS/MS) (Fig. 1A,B and supplementary Fig. S1C). SY5Y is a human cell line commonly used 
as a model for studying oxidative stress and oxidative-stress-related diseases such as Alzheimer’s and 
Parkinson’s11,12. Additionally, neuroblastomas are derived from neural crest cells, and neuronal cell types 
have high levels of hmC13, making those cells a good model for our study. BSO inhibits the synthesis of 
the antioxidant glutathione (GSH) and causes oxidative stress by generating H2O2 (Fig. 1A and supple-
mentary Fig. S1B)14. As shown in Fig. 1B, BSO-treated cells were found to have a significant decrease of 
the global hmC level. Further, this observation appeared not to be attributable to an increased apoptosis 
or necrosis, as BSO treatment did not increase the proportion of apoptotic or necrotic cells as compared 
to mock-treated cells (supplementary Fig. S1A).
Several studies have shown that BSO-treated SY5Y cells display a significant decrease in proliferation 
in response to oxidative stress15,16. We therefore measured proliferation with the xCELLigence technology, 
which records changes in conductivity that are proportional to the number of cells attached to the incu-
bation chamber. Upon treatment with BSO, the proliferation decrease was greater in TET1-knockdown 
cells than in TET2-knockdown cells or in control cells (supplementary Fig. S1D). It is worth noting 
that TET3 does not seem to be expressed in SY5Y cells, and that the effects observed here cannot be 
attributed to an off-target effect of TET1-RNAi on TET2 (supplementary Fig. S1D, and data not shown).
To confirm and extend the above findings, we used an in vivo model of oxidative stress: double-knockout 
mice lacking the genes encoding glutathione peroxidases 1 and 2 (called hereafter GPx1/2 Dko). The GPx 
enzymes are known to reduce H2O2 and are viewed as the major cellular antioxidant enzymes, especially 
in intestinal epithelial cells where reactive oxygen species accumulate upon their depletion (Fig. 1A)10. 
Dot-blot and mass spectrometry experiments were performed on GPx1/2 Dko and wild-type (wt) colon 
epithelia, and in agreement with our data on SY5Y cells, the global hmC level was found to be lower in 
GPx1/2 Dko mice than in their wt counterparts (Fig. 1C).
Our results thus suggest that hydroxymethylcytosine levels are decreased upon exogenous and in vivo 
oxidative assaults, and that SY5Y cells with reduced TET1 expression are more sensitive to oxidative 
stress.
hmC deep-sequencing profiles of BSO-treated SY5Y cells highlight pathways involved in the 
oxidative stress response. The global decrease in hmC seen upon treatment of SY5Y cells with BSO 
(Fig. 1B) led us to interrogate its genome-wide distribution. For this we used the previously described 
hmC-selective chemical labeling technique hMe-seal to selectively isolate hydroxymethylated DNA frag-
ments17, and subjected these to Illumina deep sequencing (referred here as “hmC-seq”). As previously 
described (reviewed in18), gene bodies appeared most highly represented among the captured fragments, 
exons being more enriched than introns (supplementary Fig. S2A). In agreement with the above dot-blot 
and mass spectrometry data, BSO-treated SY5Y cells displayed a significant global decrease in hmC 
(Fig. 2A, left panel).
Despite the observed global decrease of hmC, we next looked at differentially hydroxymethylated 
genes (termed “dhMGs”) to see if certain genes might locally loose or even gain hmC upon oxidative 
stress. We found 2846 dhMGs (supplementary table I), 53% of which displayed a local decrease in hmC 
and 47% a local increase (Fig. 2A, right panel). Remarkably, Ingenuity gene ontology analysis applied to 
these dhMGs revealed significant over-representation of toxicogenomic pathways associated with oxi-
dative stress response, such as mitochondrial dysfunction, decreased polarization of mitochondria, and 
cytochrome P450 response (Fig. 2B). Of note, the most highly over-represented pathways were different 
according to whether a differentially hydroxymethylated gene showed a gain or a loss of hmC: the mito-
chondrial dysfunction pathway in the former case and pathways related to the physiopathology of the 
heart, liver and kidney in the latter (supplementary Fig. S2B).
Interestingly, genes such as BCL2 or the BCL2-related MCL1 gene, found to be differentially hydrox-
ymethylated (Fig.  2C; see also sequencing tracks on Fig.  2D), are known to exert important functions 
during the oxidative stress response: Oxidative stress is attenuated in mice overexpressing BCL2, and 
the hepatitis B HBx protein sensitizes liver cells to H2O2-induced oxidative stress by reducing MCL1 
expression19,20.
Our results thus show that BSO treatment affects the hmC patterns both globally and locally, notably 
in genes important for a protective response to oxidative stress.
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Figure 1. Oxidative stress reduces the global hydroxymethylcytosine level. (A) Scheme representing 
the drug used to induce oxidative stress in SY5Y neuroblastoma cells, and a description of the mouse 
model used in this study (B) Hydroxymethylcytosine quantification by dot blot analysis (left) and mass 
spectrometry (right). SY5Y cells were treated for 48 h with 500 μ M BSO and then the global hmC content 
was evaluated on extracted genomic DNA. The data represent the amount of hmC normalized with respect 
to single-stranded DNA (dot blot) and relative to mock-treated cells. Significant differences (Student t-test) 
are indicated by * (p-value ≤ 0.05) and ** (p-value ≤ 0.01). Data represent means ± standard deviations 
of at least 3 independent experiments. (C) Hydroxymethylcytosine quantification by dot blot analysis 
(left) and mass spectrometry (right). Quantifications were performed on 5 wild-type (wt) and 5 double-
knockout (GPx1/2 Dko) mouse colon epithelial cells, and the signals were normalized with respect to single-
stranded DNA (dot blot). Mass spectrometry data shows hmC levels as a percentage of total cytosines. 
Significant differences (Student t-test) are indicated by * (p-value ≤ 0.05) and ** (p-value ≤ 0.01). See also 
supplementary Fig. S1.
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Figure 2. Genome-wide hmC sequencing after cell treatment with BSO highlights oxidative-stress-
related pathways. (A) Illumina deep sequencing was done on DNA from mock- and BSO-treated SY5Y 
cells after selective isolation of hydroxymethylated DNA fragments. Upper left panel: The global decrease in 
hmC (already demonstrated on dot blot and mass spectrometry, see Fig. 1B) is illustrated by a significant 
decrease (p-value < 10−12) in the normalized hmC- read count in BSO-treated cells. Upper right panel: 
Differentially hydroxymethylated genes (dhMGs) used in Ingenuity analyses. (B) Ingenuity toxicogenomic 
pathway analysis (“IPA-Tox”) of the dhMGs identified in SY5Y cells shows over-representation of oxidative-
stress-related pathways (marked in brown). The x axis represents the log(p-value) and the dashed line shows 
the significance threshold for pathway over-representation. (C,D) Gene list and UCSC sequencing tracks 
associated with the oxidative-stress-related pathways shown in Fig. 2B. Gene symbols, Entrez gene names, 
and hmC fold changes for BSO- vs. mock-treated SY5Y cells are depicted. Normalized BCL2 and MCL1 read 
counts are represented in (D) as examples. Small black boxes attached to arrows represent the promoters of 
these genes. See also supplementary Fig. S2.
www.nature.com/scientificreports/
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Mice lacking the glutathione peroxidases 1 and 2 display an altered hydroxymethylation on 
genes involved in the oxidative stress response. As for the above, hmC-seq experiments were 
performed on GPx1/2 wt and Dko colon epithelia, and confirmed the results obtained with SY5Y cells: 
mice lacking the GPx genes showed a significant overall decrease in hmC (Fig. 3A, left panel); reads most 
often corresponding to a gene body location and more frequently to an exon than to an intron location 
(supplementary Fig. S3A).
Figure 3. Mice lacking GPx1/2 display genome-wide hmC changes in genes involved in oxidative-stress-
related pathways. (A) Left panel: Illumina deep sequencing was done on captured hydroxymethylated 
DNA fragments from wt and GPx1/2 Dko colon epithelial cells. A global decrease in hmC is observed in 
GPx1/2 Dko cells (p-value < 10−12), representative experiment. Right panel: This panel shows dhMGs that 
were common in two independent sequencing experiments, and to which Ingenuity analysis was applied. 
(B) IPA-Tox analysis of dhMGs identified in mice reveals significant over-representation of oxidative-stress-
related pathways (marked in brown). The log(p-value) is plotted on the x axis and a dashed line shows 
the significance threshold for pathway over-representation. (C,D) Gene list and UCSC sequencing tracks 
associated with the oxidative-stress-related pathways in Fig. 3B. Gene symbols, Entrez gene names, and 
hmC fold changes for GPx1/2 Dko vs. wt are depicted. (D) Normalized Nfe2l1 (Nrf1) and Prdx6 read counts 
are represented as examples. Small black boxes attached to arrows represent the promoters of these genes 
(representative experiment). See also supplementary Fig. S3.
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We next identified 475 dhMGs (supplementary table II), 81% of which showed a local decrease in 
hmC and 19%, a local increase (Fig. 3A, right panel). Interestingly, a significant proportion of dhMGs 
were found to be involved in toxicogenomic pathways associated exclusively with oxidative stress, and 
notably with GSH depletion, precisely emphasizing GPx deletion that occurs in the Dko mice (Fig. 3B,C. 
In supplementary figure S3B, results are shown separately for genes showing a gain or loss of hmC).
As for BSO-treated SY5Y cells, we again found key genes involved in the oxidative stress response. 
Examples include Nfe2l1/Nrf1 and Prdx6 (Fig. 3C,D), whose products are known, respectively, to initi-
ate transcription of antioxidant genes and to participate in the redox regulation of the cell by reducing 
H2O221,22. It is also worth noting that our pathway analyses did not highlight the same pathways in 
BSO-treated SY5Y cells and GPx1/2 Dko mice (Figs 2B and 3B). This probably reflects the fact that the 
cultured cells were treated for only 48 h, whereas mice lacking the GPx genes were under constant oxi-
dative assault from embryogenesis to the day of sacrifice (1 month).
In summary, these results confirm restructuration of the hydroxymethylome, here in response to an 
in vivo oxidative stress, and uncover a set of genes/pathways that reflect the need for an appropriate 
cellular response.
MicroRNAs encoded by differentially hydroxymethylated genes are predicted to target tran-
scripts involved in the oxidative stress response. During our analysis of dhMGs in SY5Y cells 
and GPx1/2 wt and Dko mice, we observed an unexpected high proportion of differentially hydroxyme-
thylated microRNA-encoding sequences (Fig. 4A). MicroRNAs (miRs) are non-coding RNAs of 18 to 24 
nucleotides long that hybridize to target mRNAs and, depending on the level of complementarity, cause 
their degradation or translational repression23. As depicted in Fig. 4A, 25% of the dhMGs identified in 
SY5Y cells and 21% of those identified in GPx1/2 Dko mice were found to correspond to miR-encoding 
sequences (see also supplementary table III).
As many miR targets are conserved among mammalian species24, we examined more closely the 
miR-encoding sequences showing altered hydroxymethylation in BSO-treated SY5Y cells or in GPx1/2 
Dko mice. Of these miRs, 20 showed a robust increase or decrease in hmC in both SY5Y cells and in 
GPx1/2 Dko mice (Fig.  4B and supplementary Fig. S4). Focusing on this set of 20 miRs, we used the 
miRWalk database, a bioinformatic tool that exploits several prediction programs25, to build a compre-
hensive list of predicted mRNAs targets (Fig. 4B, and supplementary table IV). Surprisingly, Ingenuity 
pathway analysis applied to the corresponding human and mouse mRNAs revealed over-representation 
of toxicogenomic pathways involved in oxidative stress, as observed earlier (Fig. 4C; see also Figs 2B and 
3B, and supplementary Figs S2B and S3B).
These results thus suggest that hydroxymethylation pattern changes in DNA regions that do not solely 
code for proteins (here, microRNA genes), but that may contribute to determine the cellular response 
to oxidative stress.
Discussion
In this report, we have used different approaches to investigate the links between oxidative stress, the 
global hmC level, and the local distribution of this epigenetic mark. In vitro and in vivo data on SY5Y 
cells and in our mouse model show that hmC is significantly decreased upon oxidative stress. In addi-
tion, we show that TET1 depletion sensitizes SY5Y cells to oxidative stress induced by BSO, the most 
commonly used drug to increase intracellular levels of reactive oxygen species (ROS). This suggests that 
TET1, at least in part, may play a role in protecting cells against oxidative stress.
Of note, our genome-wide hmC profiling data shows a global decrease of hmC in both SY5Y cells 
and in GPx1/2 Dko mice, but locally, some of the differentially hydroxymethylated regions display an 
increase of hmC in response to oxidative stress. This increase at specific genomic loci might be caused by 
recruitment of TET enzymes to these regions in order to initiate an appropriate transcriptional program 
to respond to oxidant assaults.
Surprisingly, around 25% of the dhMGs identified here in either SY5Y or mice lie in microRNA-encoding 
sequences. In silico analyses have revealed that these miRs could target important genes involved in ROS 
detoxification. MiRs have been shown to target the transcripts of numerous genes that are associated to 
life-threatening diseases such as neurodegenerative disorders or cancer, and this set of miRs might be 
exploited, in the future, in biomarker discovery for oxidative stress related diseases26,27. The present work 
could thus be the starting point in the development of exciting biomedical applications, once we have 
gained better understanding of the links between oxidative stress and hydroxymethylcytosine patterns, 
and between miR-genes hydroxymethylation and the miR-genes transcript levels.
Of note, our study is the first that evaluated the impact of oxidative stress in vivo. On the one hand, 
prolonged oxidative stress is associated with inflammation, which is thought to precede cancer devel-
opment28. In the other hand, a decrease of hmC is now widely accepted as a hallmark of many cancers, 
linking the TET proteins to cancerogenesis29. It is thus tempting to speculate that the decrease of hmC 
observed during cancer development could be explained, at least partly, by a decrease of hmC emerging 
during oxidative stress and inflammation.
In conclusion, we propose, on the basis of our results, a model linking oxidative stress to hydroxyme-
thylcytosine patterns. Our results notably highlight the unexpected potential role of certain microRNAs in 
determining how cells respond to oxidative stress. In addition, we expect that these results, in association 
www.nature.com/scientificreports/
7Scientific RepoRts | 5:12714 | DOi: 10.1038/srep12714
Figure 4. Differentially hydroxymethylated microRNA genes highlight pathways involved in the 
oxidative stress response. (A) Percentage of dhMGs corresponding to microRNA-encoding sequences as 
compared to other genes in human SY5Y cells and mouse cells. (B) A set of 20 dhMG-associated miR genes, 
common to human and mouse, were identified and their targets predicted. Next, the identified mRNA 
targets were processed with the Ingenuity software. (C) IPA-Tox applied to the predicted S5Y5 and mouse 
mRNA targets reveals significant over-representation of oxidative-stress-related pathways (marked in brown). 
In each graph, the x axis represents the log(p-value) and the dashed line, the significance threshold for 
pathway over-representation. See also supplementary Fig. S4.
www.nature.com/scientificreports/
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with other studies, will lift the veil on molecular aspects that could explain the global decrease of hmC 
in cancers. However, additional investigation on how the TETs are recruited on genes that gain hmC, as 
well as the transcriptional effects of differential hydroxymethylation on oxidative stress-related genes and 
microRNAs, still need to be addressed and should be the subject of future studies.
Methods
Statistical analysis. Unless otherwise indicated, all experiments included technical replicates, and 
were repeated at least three independent times. Data and graphs are presented as averages ± standard 
deviations. Data were compared by means of two-tailed unpaired t-tests for comparison, and statistical 
significance was accepted at p-values ≤ 0.05. * and ** represent p-values ≤ 0.05 and ≤ 0.01, respectively. 
Statistics relative to hmC deep-sequencing analysis are further described in supplementary methods. 
Ingenuity p-values were calculated online with Fisher’s exact t-test.
Cell culture and treatments. SY5Y cells (ATCC #CRL- 2266) were maintained in 1:1 Dubelcco’s 
modified Eagle’s medium (DMEM) and F12 medium, then supplemented with 10% fetal bovine 
serum and grown at 37 °C under 5% CO2. The cells were then treated with 500 μ M BSO for 48 h. The 
mock-treatment control contained water instead of BSO.
GPx1/2-knockout mice. In our in vivo experiments, purified genomic DNA extracts obtained from 
the colon epithelia of 129 mice with combined disruption of the GPx1 and GPx2 genes were generously 
provided by Dr. F. F. Chu, and are fully described in10. The methods used on mice were carried out in 
accordance with the approved NIH guidelines, which authorize to perform all of the animal studies 
described in the related manuscript. In addition, all experimental protocols were approved by the COH 
Research Animal Care Committee (Duarte, California).
Five wild-type and five double-knockout (Dko) mice were used for hmC quantification in dot-blot 
and mass spectrometry experiments. Of these, two wild-type and two Dko mice were used for subse-
quent deep-sequencing analysis.
Dot blot for 5-hydroxymethylcytosine quantification. Dot-blot experiments were done as previ-
ously described, with some modifications30. For complete procedure, please refer to supplementary methods.
Western blot analyses. Standard procedures were used for Western blotting31. Primary antibodies used 
in these experiments were directed against TET2 (ab94580; Abcam) or HDAC1 (Diagenode; pAb-053-050).
Analysis of global hmC levels by mass spectrometry (LC/MS/MS). 500 ng of genomic DNA was 
incubated with 5 U of DNA Degradase Plus (Zymo Research) at 37 °C for 3 h. The resulting mixture of 
2’-deoxynucleosides was analysed on a Triple Quad 6500 mass spectrometer (AB Sciex) fitted with an 
Infinity 1290 LC system (Agilent) and an Acquity UPLC HSS T3 column (Waters), using a gradient of 
water and acetonitrile with 0.1% formic acid. External calibration was performed using synthetic stand-
ards, and for accurate quantification, all samples and standards were spiked with isotopically labeled 
nucleosides. HmC levels are expressed as a percentage of total cytosines.
Hydroxymethylated DNA fragment affinity purification (hMe-seal). At least 500 ng of genomic 
DNA was diluted in ultra-pure water to 35 ng/μ L and then sonicated in cold water with a Bioruptor 
sonicator (Diagenode) to obtain fragments averaging 300 bp in size. The fragmented DNA was used in 
combination with the hydroxymethyl collector (Active Motif) following to the manufacturer’s protocol. 
Briefly, a glucose moiety that contains a reactive azide group was enzymatically linked to hydroxyme-
thylcytosine in DNA, creating glucosyl-hydroxymethylcytosine. Next, a biotin conjugate was chemically 
attached to the modified glucose via a “click reaction”, and magnetic streptavidin beads were used to 
capture the biotinylated-hmC DNA fragments. After extensive washing steps and chemical elution, the 
hydroxymethylated DNA fragments released from the beads were used in sequencing experiments.
Ingenuity software. Ingenuity IPA software was used for toxicogenomic analysis (“IPA-TOX”). The 
genes and hmC fold changes were loaded into the Ingenuity database and then core analyses were done, 
using default parameters and specifying the relevant species (“Human” for SY5Y cells and “Mouse” for 
mice samples). The tissues used in the experiments were also indicated.
For further details on experimental procedures, including, RNA interference and RT-qPCR analysis, 
dot blot for 5-hydroxymethylcytosine quantification, Reactive Oxygen Species measurements, measures 
of apoptosis and necrosis, proliferation experiments, library preparation, deep sequencing workflow, and 
statistical analysis, please refer to supplementary methods.
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